Dec 7, 2007

Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy

The American Journal of Medicine
Hani JneidGary S Francis

Abstract

Neuroendocrine activation in heart failure has become the major target of pharmacotherapy for this growing epidemic. Agents targeting the renin-angiotensin-aldosterone and sympathetic nervous systems have shown cardiovascular and survival benefits in clinical trials. Beta-blockers and angiotensin-converting enzyme (ACE) inhibitors remain the mainstream initial therapy. The benefits of aldosterone antagonists have been demonstrated in advanced heart failure (spironolactone) and after myocardial infarction complicated by left ventricular dysfunction and heart failure (eplerenone). Emerging clinical evidence demonstrated that angiotensin receptor blockers may be a reasonable alternative to ACE inhibitors in patients with heart failure (candesartan) and following myocardial infarction complicated by heart failure or left ventricular dysfunction (valsartan). Angiotensin receptor blockers (candesartan) also provided incremental benefits when added to ACE inhibitors in chronic heart failure. Thus, combining neuroendocrine inhibitors in heart failure appears both biologically plausible and evidence-based. However, this approach raised concerns about side effects, such as hypotension, renal insufficiency, hyperkalemia, and others. Close...Continue Reading

Mentioned in this Paper

Biochemical Pathway
Kidney Function Tests
Creatinine
Chronic Heart Failure
Morbidity Aspects
Aldosterone Measurement
Electrolytes
Creatinine Clearance Measurement
Kidney Failure
Selective Angiotensin II Receptor Antagonists

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Related Papers

Current Treatment Options in Cardiovascular Medicine
Young-Sin Kim, Barry Greenberg
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
Christian WernerMichael Böhm
© 2020 Meta ULC. All rights reserved